Top Markets
#1 Palladium Network Palladium Network +6.67%
#2 Victoria VR Victoria VR +4.08%
#3 Bridged NXPC Bridged NXPC +2.08%
#4 Tornado Cash Tornado Cash +2.06%
#5 龙虾 (Lobster) 龙虾 (Lobster) +1.72%
#6 aixbt by Virtuals aixbt by Virtuals +1.55%
#7 Prom Prom +1.52%
#8 SkyAI SkyAI +1.49%
#9 Wiki Cat Wiki Cat +1.14%
#10 Geodnet Geodnet +0.92%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Response Genetics, Inc Response Genetics, Inc

Response Genetics, Inc

RGDXQ
Rank in Stocks #42156
Response Genetics, Inc., a life sciences company founded in Los Angeles,... Response Genetics, Inc., a life sciences company founded in Los Angeles, California, in 1999 (originally Bio Type, Inc., before its rebranding in August 2000), focuses on creating, advancing, and commercializing pharmacogenomic tests. These diagnostic tools are crucial for informing cancer treatment decisions by assessing specific indicators within tumor tissue samples that predict a patient's response to therapy. The company provides an extensive array of testing services, primarily through its ResponseDX suite, covering various cancers such as non-small cell lung, colorectal, gastric, gastroesophageal, melanoma, thyroid, breast, and glioma, in addition to a Tissue of Origin test. Beyond these existing solutions, Response Genetics is committed to expanding its diagnostic offerings to encompass other tumor types, while also delivering both the technical execution and professional interpretation components of its testing services. Operating globally, with a significant presence in the United States and Europe, Response Genetics serves a wide range of clients including community oncologists, pathologists, medical practices, hospitals, and pharmaceutical enterprises, primarily through its internal sales force.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$3.87K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Response Genetics, Inc (RGDXQ)

Category

Healthcare
Operating Margin for Response Genetics, Inc (RGDXQ)
Operating Margin as of 2026 TTM: 0.00%
According to Response Genetics, Inc latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Response Genetics, Inc from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
17.69% -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
20.42% -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00% -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
31.63% -
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
-12.97% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.